Effect of ETA/ETB receptor antagonist administration on iNOS gene expression in a rat renal transplantation model

Transplant Proc. 1999 Sep;31(6):2344-5. doi: 10.1016/s0041-1345(99)00371-1.

Authors

I Herrero¹, J Torras, J Bover, L I Espinosa, J M Cruzado, M Riera, M Hueso, N Lloberas, J Alsina, J M Grinyo

Affiliation

¹ Department of Medicine, University of Barcelona, Spain.

PMID: 10500610
DOI: 10.1016/s0041-1345(99)00371-1

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antihypertensive Agents / pharmacology
Bosentan
Endothelin Receptor Antagonists*
Gene Expression Regulation, Enzymologic / drug effects*
Kidney Transplantation / physiology*
Kidney*
Nitric Oxide Synthase / genetics*
Nitric Oxide Synthase Type II
Organ Preservation*
RNA, Messenger / genetics
Rats
Receptor, Endothelin A
Receptor, Endothelin B
Sulfonamides / pharmacology*
Transcription, Genetic / drug effects

Substances

Antihypertensive Agents
Endothelin Receptor Antagonists
RNA, Messenger
Receptor, Endothelin A
Receptor, Endothelin B
Sulfonamides
Nitric Oxide Synthase
Nitric Oxide Synthase Type II
Nos2 protein, rat
Bosentan